International Pharmaceutical Aerosol Consortium on Regulation & Science

The International Pharmaceutical Aerosol Consortium on Regulation & Science (IPAC-RS) is an international association that seeks to advance the science, and especially the regulatory science, of orally inhaled and nasal drug products (OINDPs) by collecting and analyzing data, and conducting joint research and development projects. Representing the OINDP industry since 2000, IPAC-RS aims to build consensus and contribute to effective regulations and standards by sharing the results of its research through conferences, technical journals, webinars, and discussions with regulatory bodies.

News and Events

May 2021
IPAC-RS engages actively in reviewing and commenting on regulatory developments around the world, and works collaboratively with all stakeholders to improve science-based regulations affecting orally inhaled and intranasal pharmaceutical products.  IPAC-RS has prepared a summary of relevant global regulatory developments in 2020.   


IPAC-RS Regulatory Roundtable Webinar Series
IPAC-RS hosted a Roundtable: A Conversation with the FDA: Perspectives in the Time of COVID-19 on November 2, 2020.

Click here to review the summary of the webinar.

July 2020
Visit the IPAC-RS Pharmaceutical Aerosols Resource Center (PARC) to learn about science and regulation of medicinal aerosols and delivery systems – including those involved in addressing COVID-19.   Contact us with questions or suggestions.



Become an IPAC-RS member today!

Inquire below.

Thanks for submitting!